WO2002038127A3 - Particle formation methods and their products - Google Patents
Particle formation methods and their products Download PDFInfo
- Publication number
- WO2002038127A3 WO2002038127A3 PCT/GB2001/004873 GB0104873W WO0238127A3 WO 2002038127 A3 WO2002038127 A3 WO 2002038127A3 GB 0104873 W GB0104873 W GB 0104873W WO 0238127 A3 WO0238127 A3 WO 0238127A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- additive
- active substance
- particle formation
- particles
- products
- Prior art date
Links
- 239000002245 particle Substances 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 3
- 230000015572 biosynthetic process Effects 0.000 title abstract 2
- 239000000654 additive Substances 0.000 abstract 7
- 230000000996 additive effect Effects 0.000 abstract 7
- 239000013543 active substance Substances 0.000 abstract 3
- 239000012296 anti-solvent Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000012530 fluid Substances 0.000 abstract 1
- 230000000873 masking effect Effects 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/30—Physical treatment, e.g. electrical or magnetic means, wave energy or irradiation
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D9/00—Crystallisation
- B01D9/005—Selection of auxiliary, e.g. for control of crystallisation nuclei, of crystal growth, of adherence to walls; Arrangements for introduction thereof
- B01D9/0054—Use of anti-solvent
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
Abstract
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MXPA03003846A MXPA03003846A (en) | 2000-11-09 | 2001-11-01 | Particle formation methods and their products. |
JP2002540717A JP4880863B2 (en) | 2000-11-09 | 2001-11-01 | Particle forming method and product thereof |
CA2426247A CA2426247C (en) | 2000-11-09 | 2001-11-01 | Particle formation methods and their products |
DE60132230T DE60132230T2 (en) | 2000-11-09 | 2001-11-01 | PROCESS FOR THE PRODUCTION OF PARTICLES AND THEIR PRODUCTS |
KR1020037006171A KR100822098B1 (en) | 2000-11-09 | 2001-11-01 | Particle formation methods and their products |
AU2002210765A AU2002210765B9 (en) | 2000-11-09 | 2001-11-01 | Particle formation methods and their products |
EP01978670A EP1331928B1 (en) | 2000-11-09 | 2001-11-01 | Particle formation methods and their products |
AU1076502A AU1076502A (en) | 2000-11-09 | 2001-11-01 | Particle formation methods and their products |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0027357A GB0027357D0 (en) | 2000-11-09 | 2000-11-09 | Particle formation methods and their products |
GB0027357.3 | 2000-11-09 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002038127A2 WO2002038127A2 (en) | 2002-05-16 |
WO2002038127A3 true WO2002038127A3 (en) | 2003-01-09 |
Family
ID=9902848
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2001/004873 WO2002038127A2 (en) | 2000-11-09 | 2001-11-01 | Particle formation methods and their products |
Country Status (13)
Country | Link |
---|---|
US (4) | US7115280B2 (en) |
EP (1) | EP1331928B1 (en) |
JP (1) | JP4880863B2 (en) |
KR (1) | KR100822098B1 (en) |
AT (1) | ATE382336T1 (en) |
AU (2) | AU1076502A (en) |
CA (1) | CA2426247C (en) |
DE (1) | DE60132230T2 (en) |
ES (1) | ES2299519T3 (en) |
GB (3) | GB0027357D0 (en) |
MX (1) | MXPA03003846A (en) |
TW (1) | TWI241198B (en) |
WO (1) | WO2002038127A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9120031B2 (en) | 2000-11-09 | 2015-09-01 | Nektar Therapeutics | Compositions of particulate coformulation |
Families Citing this family (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9703673D0 (en) * | 1997-02-21 | 1997-04-09 | Bradford Particle Design Ltd | Method and apparatus for the formation of particles |
GB9810559D0 (en) * | 1998-05-15 | 1998-07-15 | Bradford Particle Design Ltd | Method and apparatus for particle formation |
DE10026698A1 (en) | 2000-05-30 | 2001-12-06 | Basf Ag | Self-emulsifying active ingredient formulation and use of this formulation |
US8268333B2 (en) * | 2001-04-24 | 2012-09-18 | Lintec Corporation | Orally administered agent and an orally administered agent/supporting substrate complex |
JP4993652B2 (en) * | 2004-03-31 | 2012-08-08 | リンテック株式会社 | Oral administration |
EP1391212A4 (en) * | 2001-04-24 | 2008-09-03 | Lintec Corp | Oral preparations and supports for oral preparations |
GB0208742D0 (en) | 2002-04-17 | 2002-05-29 | Bradford Particle Design Ltd | Particulate materials |
GB0117696D0 (en) * | 2001-07-20 | 2001-09-12 | Bradford Particle Design Plc | Particle information |
GB0216562D0 (en) | 2002-04-25 | 2002-08-28 | Bradford Particle Design Ltd | Particulate materials |
US9339459B2 (en) | 2003-04-24 | 2016-05-17 | Nektar Therapeutics | Particulate materials |
CA2510019A1 (en) * | 2002-12-19 | 2004-07-08 | Baxter International, Inc. | Process for preparing combination pharmaceutical formulations using supercritical fluids |
GB0310636D0 (en) * | 2003-05-08 | 2003-06-11 | Nektar Therapeutics Uk Ltd | Particulate materials |
US7354601B2 (en) * | 2003-05-08 | 2008-04-08 | Walker Stephen E | Particulate materials |
US8377952B2 (en) | 2003-08-28 | 2013-02-19 | Abbott Laboratories | Solid pharmaceutical dosage formulation |
US8025899B2 (en) | 2003-08-28 | 2011-09-27 | Abbott Laboratories | Solid pharmaceutical dosage form |
KR100603974B1 (en) | 2003-12-05 | 2006-07-25 | 김갑식 | Method for preparing nano-scale or amorphous particle using solid fat as a solvent |
WO2005072710A2 (en) | 2004-01-28 | 2005-08-11 | Johns Hopkins University | Drugs and gene carrier particles that rapidly move through mucous barriers |
JP2005298471A (en) * | 2004-03-17 | 2005-10-27 | Lintec Corp | Method for producing medicine |
JP2005289867A (en) * | 2004-03-31 | 2005-10-20 | Lintec Corp | Agent for peroral administration |
US7507823B2 (en) | 2004-05-06 | 2009-03-24 | Bristol-Myers Squibb Company | Process of making aripiprazole particles |
US7351423B2 (en) * | 2004-09-01 | 2008-04-01 | Depuy Spine, Inc. | Musculo-skeletal implant having a bioactive gradient |
US20060147516A1 (en) * | 2005-01-06 | 2006-07-06 | Cima Labs Inc. | Taste masking system for alprazolam |
WO2007009164A1 (en) * | 2005-07-15 | 2007-01-25 | Eiffel Technologies Limited | Method of particle formation |
GB0602637D0 (en) * | 2006-02-09 | 2006-03-22 | Glaxo Group Ltd | Novel process |
WO2007136129A1 (en) * | 2006-05-23 | 2007-11-29 | Takeda Pharmaceutical Company Limited | Oral preparation comprising pioglitazone |
WO2008030557A2 (en) * | 2006-09-08 | 2008-03-13 | Johns Hopkins University | Compositions and methods for enhancing transport through mucus |
ES2390183T3 (en) * | 2006-10-11 | 2012-11-07 | Crititech, Inc. | Method of precipitation of small particles of medicine in use container |
US20080132560A1 (en) * | 2006-11-21 | 2008-06-05 | San-Laung Chow | Solid dispersion composition |
KR20090129998A (en) | 2007-02-11 | 2009-12-17 | 맵 파마슈티컬스, 인코포레이티드 | Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile |
WO2009085828A2 (en) * | 2007-12-20 | 2009-07-09 | Mutual Pharmaceutical Company, Inc. | Quinine sulfate polymorphs, processes of preparing, compositions and uses thereof |
US20090197963A1 (en) * | 2008-02-01 | 2009-08-06 | Dan Llewellyn | Method and compositions for suppressing appetite or treating obesity |
WO2010002675A2 (en) * | 2008-06-30 | 2010-01-07 | Mutual Pharmaceutical Company, Inc. | Quinine sulfate/bisulfate solid complex; methods of making; and methods of use thereof |
CA2732655A1 (en) * | 2008-07-31 | 2010-02-04 | Feyecon B.V. | Microencapsulate and process for the manufacture thereof |
US8889193B2 (en) | 2010-02-25 | 2014-11-18 | The Johns Hopkins University | Sustained delivery of therapeutic agents to an eye compartment |
CA2793241C (en) | 2010-03-22 | 2020-07-14 | Bio-Synectics Inc. | Method for preparing nano-particles |
US9327037B2 (en) | 2011-02-08 | 2016-05-03 | The Johns Hopkins University | Mucus penetrating gene carriers |
MX350838B (en) | 2011-02-11 | 2017-09-18 | Grain Proc Corporation * | Salt composition. |
EA030318B1 (en) | 2012-03-16 | 2018-07-31 | Дзе Джонс Хопкинс Юниверсити | Non-linear multiblock copolymer-drug conjugates for the delivery of active agents |
US8962577B2 (en) | 2012-03-16 | 2015-02-24 | The Johns Hopkins University | Controlled release formulations for the delivery of HIF-1 inhibitors |
US11596599B2 (en) | 2012-05-03 | 2023-03-07 | The Johns Hopkins University | Compositions and methods for ophthalmic and/or other applications |
JP6360039B2 (en) | 2012-05-03 | 2018-07-18 | カラ ファーマシューティカルズ インコーポレイテッド | Composition comprising a plurality of coated particles, pharmaceutical composition, pharmaceutical formulation and method of forming the particles |
EP2844227B1 (en) | 2012-05-03 | 2020-11-18 | Kala Pharmaceuticals, Inc. | Pharmaceutical nanoparticles showing improved mucosal transport |
US9827191B2 (en) | 2012-05-03 | 2017-11-28 | The Johns Hopkins University | Compositions and methods for ophthalmic and/or other applications |
US9533068B2 (en) | 2012-05-04 | 2017-01-03 | The Johns Hopkins University | Drug loaded microfiber sutures for ophthalmic application |
EP2919594A4 (en) * | 2012-11-14 | 2016-08-31 | Pepsico Inc | Method to improve dispersibility of a material having low solubility in water |
US10568975B2 (en) | 2013-02-05 | 2020-02-25 | The Johns Hopkins University | Nanoparticles for magnetic resonance imaging tracking and methods of making and using thereof |
WO2014127214A1 (en) | 2013-02-15 | 2014-08-21 | Kala Pharmaceuticals, Inc. | Therapeutic compounds and uses thereof |
ES2831625T3 (en) | 2013-02-20 | 2021-06-09 | Kala Pharmaceuticals Inc | Therapeutic compounds and their uses |
US9688688B2 (en) | 2013-02-20 | 2017-06-27 | Kala Pharmaceuticals, Inc. | Crystalline forms of 4-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxyquinazolin-7-yl)oxy)-1-(2-oxa-7-azaspiro[3.5]nonan-7-yl)butan-1-one and uses thereof |
US9987233B2 (en) | 2013-03-21 | 2018-06-05 | Eupraxia Pharmaceuticals USA LLC | Injectable sustained release composition and method of using the same for treating inflammation in joints and pain associated therewith |
US9890173B2 (en) | 2013-11-01 | 2018-02-13 | Kala Pharmaceuticals, Inc. | Crystalline forms of therapeutic compounds and uses thereof |
JP6426194B2 (en) | 2013-11-01 | 2018-11-21 | カラ ファーマシューティカルズ インコーポレイテッド | Crystalline forms of therapeutic compounds and uses thereof |
CA2960860A1 (en) * | 2014-09-19 | 2016-03-24 | Eupraxia Pharmaceuticals Inc. | Injectable microparticles for hyper-localized release of therapeutic agents |
AU2016211696B2 (en) | 2015-01-27 | 2018-05-10 | The Johns Hopkins University | Hypotonic hydrogel formulations for enhanced transport of active agents at mucosal surfaces |
EP3206672B1 (en) | 2015-10-27 | 2018-03-14 | Eupraxia Pharmaceuticals Inc. | Sustained release formulations of local anesthetics |
EA038755B1 (en) | 2015-11-12 | 2021-10-14 | Грейбаг Вижн, Инк. | Aggregating microparticles for providing sustained release of a therapeuic agent for intraocular delivery |
US10253036B2 (en) | 2016-09-08 | 2019-04-09 | Kala Pharmaceuticals, Inc. | Crystalline forms of therapeutic compounds and uses thereof |
US10392399B2 (en) | 2016-09-08 | 2019-08-27 | Kala Pharmaceuticals, Inc. | Crystalline forms of therapeutic compounds and uses thereof |
EP3509421A4 (en) | 2016-09-08 | 2020-05-20 | Kala Pharmaceuticals, Inc. | Crystalline forms of therapeutic compounds and uses thereof |
AU2018240462C1 (en) | 2017-03-23 | 2022-12-08 | Graybug Vision, Inc. | Drugs and compositions for the treatment of ocular disorders |
CN111201040A (en) | 2017-05-10 | 2020-05-26 | 灰色视觉公司 | Sustained release microparticles and suspensions thereof for medical therapy |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5424076A (en) * | 1990-12-22 | 1995-06-13 | Schwarz Pharma Ag | Method of producing microscopic particles made of hydrolytically decomposable polymers and containing active substances |
WO1998013136A1 (en) * | 1996-09-25 | 1998-04-02 | Mainelab | Method for preparing microcapsules of active substances coated with a polymer and novel microcapsules in particular resulting from the method |
US5795594A (en) * | 1993-07-01 | 1998-08-18 | Glaxo Group Limited | Salmeterol xinafoate with controlled particle size |
WO1999059710A1 (en) * | 1998-05-15 | 1999-11-25 | Bradford Particle Design Plc. | Methods and apparatus for particle formation |
WO2001003821A1 (en) * | 1999-07-07 | 2001-01-18 | Bradford Particle Design Limited | Method of particle formation |
WO2001045731A1 (en) * | 1999-12-21 | 2001-06-28 | Rxkinetix, Inc. | Particulate drug-containing products and method of manufacture |
Family Cites Families (151)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1122284A (en) | 1965-03-19 | 1968-08-07 | Fisons Pharmaceuticals Ltd | Inhalation device |
JPS5254709A (en) * | 1975-10-31 | 1977-05-04 | Lion Corp | Multi-stage spray drying method |
SE418247B (en) * | 1975-11-17 | 1981-05-18 | Haessle Ab | SET TO MAKE BODIES WITH REGULATED RELEASE OF AN ACTIVE COMPONENT |
FI54093C (en) * | 1976-12-20 | 1978-10-10 | Outokumpu Oy | SAETT ATT FRAMSTAELLA PULVERFORMIGT SELEN FRAON RAOSELEN |
DE3013839A1 (en) * | 1979-04-13 | 1980-10-30 | Freunt Ind Co Ltd | METHOD FOR PRODUCING AN ACTIVATED PHARMACEUTICAL COMPOSITION |
JPS6034925B2 (en) * | 1979-07-31 | 1985-08-12 | 帝人株式会社 | Long-acting nasal preparation and its manufacturing method |
WO1981002975A1 (en) | 1980-04-21 | 1981-10-29 | Univ California | Prolonged action drug formulation |
US4423099A (en) * | 1980-07-28 | 1983-12-27 | Ciba-Geigy Corporation | Membrane modified hydrogels |
US4397907A (en) * | 1981-06-22 | 1983-08-09 | Hughes Aircraft Company | Multi-purpose air permeable composites |
EP0072046B1 (en) | 1981-07-24 | 1986-01-15 | FISONS plc | Inhalation drugs, methods for their production and pharmaceutical formulations containing them |
GB2105189B (en) | 1981-07-24 | 1985-03-20 | Fisons Plc | Inhalation drugs |
US5260306A (en) * | 1981-07-24 | 1993-11-09 | Fisons Plc | Inhalation pharmaceuticals |
CH656077A5 (en) * | 1982-01-29 | 1986-06-13 | Glatt Maschinen & Apparatebau | METHOD FOR COATING PARTICLES, IN PARTICULAR MEDICINE PARTICLES, AND DEVICE FOR IMPLEMENTING THE METHOD. |
JPS59163313A (en) | 1983-03-09 | 1984-09-14 | Teijin Ltd | Peptide hormone composition for nasal administration |
US4486435A (en) | 1983-05-16 | 1984-12-04 | Basf Wyandotte Corporation | Spray-dried vitamin powders using hydrophobic silica |
US4582731A (en) * | 1983-09-01 | 1986-04-15 | Battelle Memorial Institute | Supercritical fluid molecular spray film deposition and powder formation |
US4514574A (en) * | 1984-01-09 | 1985-04-30 | The Dow Chemical Company | Process for separating isomeric mixtures |
US4568559A (en) * | 1984-02-06 | 1986-02-04 | Biotek, Inc. | Composite core coated microparticles and process of preparing same |
US4749576A (en) * | 1984-05-10 | 1988-06-07 | Ciba-Geigy Corporation | Active agent containing hydrogel devices wherein the active agent concentration profile contains a sigmoidal concentration gradient for improved constant release, their manufacture and use |
US4624848A (en) | 1984-05-10 | 1986-11-25 | Ciba-Geigy Corporation | Active agent containing hydrogel devices wherein the active agent concentration profile contains a sigmoidal concentration gradient for improved constant release, their manufacture and use |
IE58110B1 (en) | 1984-10-30 | 1993-07-14 | Elan Corp Plc | Controlled release powder and process for its preparation |
ES2053549T3 (en) * | 1986-08-11 | 1994-08-01 | Innovata Biomed Ltd | A PROCESS FOR THE PREPARATION OF AN APPROPRIATE PHARMACEUTICAL FORMULATION FOR INHALATION. |
US4760093A (en) | 1986-10-21 | 1988-07-26 | American Home Products Corporation (Del.) | Spray dried acetaminophen |
JP2562624B2 (en) * | 1986-11-07 | 1996-12-11 | 昭和電工株式会社 | Water-soluble microcapsule and liquid detergent composition |
NZ222907A (en) | 1986-12-16 | 1990-08-28 | Novo Industri As | Preparation for intranasal administration containing a phospholipid absorption enhancing system |
US4784878A (en) * | 1987-04-06 | 1988-11-15 | Damrow Company, Inc. | Spray drying method and apparatus for concurrent particle coating |
SE8701479L (en) | 1987-04-09 | 1988-10-10 | Carbomatrix Ab | METHOD FOR CONTAINING BIOLOGICALLY EFFECTIVE PREPARATIONS AND USE THEREOF |
GB8712176D0 (en) | 1987-05-22 | 1987-06-24 | Cosmas Damian Ltd | Drug delivery system |
US4835187A (en) | 1987-06-15 | 1989-05-30 | American Home Products Corporation | Spray dried ibuprofen |
US5219575A (en) * | 1987-06-26 | 1993-06-15 | Duphar International Research B.V. | Compositions with controlled zero-order delivery rate and method of preparing these compositions |
DE3787533T2 (en) * | 1987-12-21 | 1994-01-20 | Union Carbide Corp | Use of supercritical liquids as a thinner when spraying coatings. |
DE3744329A1 (en) | 1987-12-28 | 1989-07-06 | Schwarz Pharma Gmbh | METHOD FOR THE PRODUCTION OF AT LEAST ONE ACTIVE AGENT AND A TRAITER COMPRISING PREPARATION |
JPH01176437A (en) | 1987-12-29 | 1989-07-12 | Ono Pharmaceut Co Ltd | Method for rendering organic substance into fine particles |
US4919853A (en) * | 1988-01-21 | 1990-04-24 | The United States Of America As Represented By The United States Department Of Energy | Apparatus and method for spraying liquid materials |
ES2047547T3 (en) | 1988-06-03 | 1994-03-01 | Niro Sterner Inc | DEHYDRATION METHOD BY SPRAY AND APPARATUS FOR SIMULTANEOUS COATING OF PARTICLES. |
US5066522A (en) * | 1988-07-14 | 1991-11-19 | Union Carbide Chemicals And Plastics Technology Corporation | Supercritical fluids as diluents in liquid spray applications of adhesives |
EP0360340A1 (en) | 1988-09-19 | 1990-03-28 | Akzo N.V. | Composition for nasal administration containing a peptide |
AU624421B2 (en) | 1988-10-05 | 1992-06-11 | Pharmacia & Upjohn Company | Finely divided solid crystalline powders via precipitation into an anti-solvent |
US4999189A (en) * | 1988-11-14 | 1991-03-12 | Schering Corporation | Sustained release oral suspensions |
GB8903593D0 (en) | 1989-02-16 | 1989-04-05 | Pafra Ltd | Storage of materials |
US5009367A (en) | 1989-03-22 | 1991-04-23 | Union Carbide Chemicals And Plastics Technology Corporation | Methods and apparatus for obtaining wider sprays when spraying liquids by airless techniques |
US5232707A (en) * | 1989-07-10 | 1993-08-03 | Syntex (U.S.A.) Inc. | Solvent extraction process |
US5238920A (en) * | 1989-08-22 | 1993-08-24 | Abbott Laboratories | Pulmonary surfactant protein fragments |
US5178878A (en) * | 1989-10-02 | 1993-01-12 | Cima Labs, Inc. | Effervescent dosage form with microparticles |
US5376386A (en) | 1990-01-24 | 1994-12-27 | British Technology Group Limited | Aerosol carriers |
GB9001635D0 (en) * | 1990-01-24 | 1990-03-21 | Ganderton David | Aerosol carriers |
US5000888A (en) * | 1990-05-23 | 1991-03-19 | Basf Corporation | Process for spray drying riboflavin to produce a granulate product having low binder content |
EP0461930B1 (en) | 1990-06-15 | 1995-09-13 | Merck & Co. Inc. | A crystallization method to improve crystal structure and size |
GB9017155D0 (en) | 1990-08-03 | 1990-09-19 | Ici Plc | Spray drying |
JP3080983B2 (en) | 1990-11-21 | 2000-08-28 | 東芝タンガロイ株式会社 | Hard sintered alloy having gradient composition structure and method for producing the same |
DE4118230A1 (en) * | 1990-12-20 | 1992-06-25 | Bayer Ag | METHOD OF ISOLATING POLYMERS FROM THEIR SOLVENTS WITH CARBON DIOXIDE-CONTAINING LIQUIDS |
GB9107628D0 (en) | 1991-04-10 | 1991-05-29 | Moonbrook Limited | Preparation of diagnostic agents |
US5993805A (en) * | 1991-04-10 | 1999-11-30 | Quadrant Healthcare (Uk) Limited | Spray-dried microparticles and their use as therapeutic vehicles |
DE4117751A1 (en) * | 1991-05-30 | 1992-12-03 | Bayer Ag | METHOD FOR INSULATING POLYCARBONATES |
GB9116610D0 (en) | 1991-08-01 | 1991-09-18 | Danbiosyst Uk | Preparation of microparticles |
US5269980A (en) | 1991-08-05 | 1993-12-14 | Northeastern University | Production of polymer particles in powder form using an atomization technique |
DE69220317T2 (en) * | 1991-10-01 | 1997-10-16 | Takeda Chemical Industries Ltd | Microparticle summary for extended release and manufacture of the same |
US6063910A (en) | 1991-11-14 | 2000-05-16 | The Trustees Of Princeton University | Preparation of protein microparticles by supercritical fluid precipitation |
ATE146359T1 (en) * | 1992-01-21 | 1997-01-15 | Stanford Res Inst Int | IMPROVED METHOD FOR PRODUCING MICRONIZED POLYPEPTIDE DRUGS |
US5639441A (en) | 1992-03-06 | 1997-06-17 | Board Of Regents Of University Of Colorado | Methods for fine particle formation |
EP0611567B1 (en) | 1992-06-12 | 2002-08-28 | Teijin Limited | Ultrafine powder for inhalation and production thereof |
AU4198793A (en) * | 1992-07-24 | 1994-01-27 | Takeda Chemical Industries Ltd. | Microparticle preparation and production thereof |
AU678788B2 (en) * | 1992-11-02 | 1997-06-12 | Ferro Corporation | Method of preparing coating materials |
AU660852B2 (en) * | 1992-11-25 | 1995-07-06 | Elan Pharma International Limited | Method of grinding pharmaceutical substances |
KR950703935A (en) * | 1992-11-30 | 1995-11-17 | 밋첼 아이, 커시너 | Pharmaceutical compositions that block taste |
GB9226474D0 (en) | 1992-12-18 | 1993-02-10 | Ici Plc | Production of particulate materials |
US5354934A (en) * | 1993-02-04 | 1994-10-11 | Amgen Inc. | Pulmonary administration of erythropoietin |
US5916596A (en) | 1993-02-22 | 1999-06-29 | Vivorx Pharmaceuticals, Inc. | Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
IL105658A (en) | 1993-05-11 | 1995-10-31 | Ultrasonic Dryer Ltd | Spray drying system |
US5554382A (en) * | 1993-05-28 | 1996-09-10 | Aphios Corporation | Methods and apparatus for making liposomes |
IS1796B (en) * | 1993-06-24 | 2001-12-31 | Ab Astra | Inhaled polypeptide formulation composition which also contains an enhancer compound |
GB9313642D0 (en) * | 1993-07-01 | 1993-08-18 | Glaxo Group Ltd | Method and apparatus for the formation of particles |
KR960011238B1 (en) * | 1993-07-05 | 1996-08-21 | 주식회사 코오롱 | Omeprazole preparation and its process |
EP0728037B1 (en) * | 1993-11-08 | 1999-01-13 | The Gillette Company | Method of forming particles using a supercritical fluid, aerogel particles formed thereby, and antiperspirants containing aerogel particles |
IT1265473B1 (en) | 1993-12-30 | 1996-11-22 | Otefal Srl | PROCEDURE FOR THE PRODUCTION OF POWDERS WITH CONTROLLED GRANULOMETRY AND PRODUCT IN POWDER SO OBTAINED |
US5595761A (en) * | 1994-01-27 | 1997-01-21 | The Board Of Regents Of The University Of Oklahoma | Particulate support matrix for making a rapidly dissolving tablet |
US5635210A (en) * | 1994-02-03 | 1997-06-03 | The Board Of Regents Of The University Of Oklahoma | Method of making a rapidly dissolving tablet |
AU680727B2 (en) * | 1994-02-09 | 1997-08-07 | Kinerton Limited | Process for drying a material from solution |
SI9400079B (en) | 1994-02-15 | 2003-02-28 | Dr. Weidner Eckhard, Dipl. Ing. | Method and device for extraction and fractionation of small particles from solutions saturated with gas |
US6051256A (en) | 1994-03-07 | 2000-04-18 | Inhale Therapeutic Systems | Dispersible macromolecule compositions and methods for their preparation and use |
JPH081882A (en) | 1994-06-20 | 1996-01-09 | Chisso Corp | Laminated film made of polyolefinic resin |
JP3883588B2 (en) | 1994-06-22 | 2007-02-21 | 大日本印刷株式会社 | Cosmetic material |
JP3175482B2 (en) | 1994-06-23 | 2001-06-11 | 凸版印刷株式会社 | Decorative sheet and method for producing the same |
JP3093103B2 (en) | 1994-06-24 | 2000-10-03 | 住友ベークライト株式会社 | Multilayer film |
GB9413202D0 (en) * | 1994-06-30 | 1994-08-24 | Univ Bradford | Method and apparatus for the formation of particles |
US6290991B1 (en) | 1994-12-02 | 2001-09-18 | Quandrant Holdings Cambridge Limited | Solid dose delivery vehicle and methods of making same |
US5499848A (en) | 1994-09-26 | 1996-03-19 | Bundy Corporation | Connection verifier for a quick connector coupling |
US6117455A (en) | 1994-09-30 | 2000-09-12 | Takeda Chemical Industries, Ltd. | Sustained-release microcapsule of amorphous water-soluble pharmaceutical active agent |
US5716558A (en) * | 1994-11-14 | 1998-02-10 | Union Carbide Chemicals & Plastics Technology Corporation | Method for producing coating powders catalysts and drier water-borne coatings by spraying compositions with compressed fluids |
MX9504934A (en) * | 1994-12-12 | 1997-01-31 | Morton Int Inc | Smooth thin film powder coatings. |
US5639475A (en) * | 1995-02-03 | 1997-06-17 | Eurand America, Incorporated | Effervescent microcapsules |
US5510118A (en) * | 1995-02-14 | 1996-04-23 | Nanosystems Llc | Process for preparing therapeutic compositions containing nanoparticles |
US6258341B1 (en) * | 1995-04-14 | 2001-07-10 | Inhale Therapeutic Systems, Inc. | Stable glassy state powder formulations |
US5495681A (en) | 1995-05-24 | 1996-03-05 | Paradis; Andr´E | Pivotable panel for clothes dryer drum |
US5667806A (en) * | 1995-06-07 | 1997-09-16 | Emisphere Technologies, Inc. | Spray drying method and apparatus |
US5607697A (en) * | 1995-06-07 | 1997-03-04 | Cima Labs, Incorporated | Taste masking microparticles for oral dosage forms |
JP3541090B2 (en) * | 1995-09-08 | 2004-07-07 | 三洋電機株式会社 | Positive active material for alkaline storage battery and method for producing the same |
CA2234957C (en) | 1995-10-17 | 2006-12-19 | Inge B. Henriksen | Insoluble drug delivery |
US5807578A (en) * | 1995-11-22 | 1998-09-15 | Lab Pharmaceutical Research International Inc. | Fast-melt tablet and method of making same |
US5874029A (en) * | 1996-10-09 | 1999-02-23 | The University Of Kansas | Methods for particle micronization and nanonization by recrystallization from organic solutions sprayed into a compressed antisolvent |
AU709384B2 (en) * | 1996-03-01 | 1999-08-26 | University Of Kansas, The | Methods and apparatus for particle precipitation and coating using near-critical and supercritical antisolvents |
DE19617487A1 (en) * | 1996-05-02 | 1997-11-06 | Merck Patent Gmbh | Taste improvement of active pharmaceutical ingredients |
US6197835B1 (en) * | 1996-05-13 | 2001-03-06 | Universidad De Sevilla | Device and method for creating spherical particles of uniform size |
ES2140998B1 (en) * | 1996-05-13 | 2000-10-16 | Univ Sevilla | LIQUID ATOMIZATION PROCEDURE. |
US5985309A (en) * | 1996-05-24 | 1999-11-16 | Massachusetts Institute Of Technology | Preparation of particles for inhalation |
US5855913A (en) * | 1997-01-16 | 1999-01-05 | Massachusetts Instite Of Technology | Particles incorporating surfactants for pulmonary drug delivery |
JP4036233B2 (en) | 1996-08-09 | 2008-01-23 | ヤマハ株式会社 | Musical sound generating device, musical sound generating method, and storage medium storing a program related to the method |
US6017310A (en) * | 1996-09-07 | 2000-01-25 | Andaris Limited | Use of hollow microcapsules |
ATE222231T1 (en) * | 1996-09-18 | 2002-08-15 | Daiso Co Ltd | METHOD FOR PRODUCING 3-AMINO-2-HYDROXY-1-PROPYL ETHERS |
GB9622173D0 (en) | 1996-10-24 | 1996-12-18 | Glaxo Group Ltd | Particulate Products |
JP2001507702A (en) | 1996-12-31 | 2001-06-12 | インヘイル・セラピューティックス・システムズ・インコーポレテッド | Method for spray drying an aqueous suspension of a hydrophobic drug having a hydrophilic excipient and a composition made by the method |
US20030203036A1 (en) * | 2000-03-17 | 2003-10-30 | Gordon Marc S. | Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients |
GB9703673D0 (en) | 1997-02-21 | 1997-04-09 | Bradford Particle Design Ltd | Method and apparatus for the formation of particles |
US6051257A (en) * | 1997-02-24 | 2000-04-18 | Superior Micropowders, Llc | Powder batch of pharmaceutically-active particles and methods for making same |
US6024981A (en) | 1997-04-16 | 2000-02-15 | Cima Labs Inc. | Rapidly dissolving robust dosage form |
GB9800936D0 (en) * | 1997-05-10 | 1998-03-11 | Univ Nottingham | Biofunctional polymers |
WO1998053940A1 (en) | 1997-05-28 | 1998-12-03 | Siemens Aktiengesellschaft | Metal-ceramic graded-index material, product produced from said material, and method for producing the material |
US6565885B1 (en) * | 1997-09-29 | 2003-05-20 | Inhale Therapeutic Systems, Inc. | Methods of spray drying pharmaceutical compositions |
WO1999017742A2 (en) | 1997-10-03 | 1999-04-15 | Elan Corporation, Plc | Taste masked formulations |
US5904937A (en) | 1997-10-03 | 1999-05-18 | Fmc Corporation | Taste masked pharmaceutical compositions |
US6426116B1 (en) | 1997-10-15 | 2002-07-30 | University Of South Florida | Supercritical fluid aided coating of particulate material |
DE69806504T2 (en) | 1997-12-17 | 2003-02-27 | Univ De Sevilla Sevilla | METHOD FOR PRODUCING HOLLOW DROPLES |
JPH11197494A (en) * | 1998-01-13 | 1999-07-27 | Kenji Mishima | Microparticle coating using supercritical fluid |
GB9804379D0 (en) | 1998-03-02 | 1998-04-22 | Bradford Particle Design Ltd | Method of particle formation |
SE9801288D0 (en) | 1998-04-14 | 1998-04-14 | Astra Ab | Vaccine delivery system and method of production |
US6387410B1 (en) * | 1998-09-10 | 2002-05-14 | Norton Healthcare Ltd | Anti-inflammatory pharmaceutical formulations |
SE9804001D0 (en) | 1998-11-23 | 1998-11-23 | Astra Ab | New process |
SE9804003D0 (en) | 1998-11-23 | 1998-11-23 | Astra Ab | A method of producing drug particles |
CA2351720C (en) | 1998-11-25 | 2006-11-21 | Cima Labs Inc. | Taste masking rapid release coating system |
GB9825883D0 (en) | 1998-11-27 | 1999-01-20 | Aea Technology Plc | Formation of monodisperse particles |
ATE404178T1 (en) * | 1999-02-10 | 2008-08-15 | Pfizer Prod Inc | DEVICE WITH MATRIX-CONTROLLED ACTIVE RELEASE |
SE9901667D0 (en) | 1999-05-07 | 1999-05-07 | Astra Ab | Method and device for forming particles |
FR2795962B1 (en) | 1999-07-08 | 2003-05-09 | Prographarm Laboratoires | PROCESS FOR THE MANUFACTURE OF MASK TASTE COATED GRANULES AND IMMEDIATE RELEASE OF THE ACTIVE INGREDIENT |
US20020081266A1 (en) * | 1999-08-20 | 2002-06-27 | Norton Healthcare Ltd. | Spray dried powders for pulmonary or nasal administration |
GB9920558D0 (en) | 1999-08-31 | 1999-11-03 | Bradford Particle Design Ltd | Methods for particle formation and their products |
PE20011227A1 (en) * | 2000-04-17 | 2002-01-07 | Chiesi Farma Spa | PHARMACEUTICAL FORMULATIONS FOR DRY POWDER INHALERS IN THE FORM OF HARD AGGLOMERATES |
US6551617B1 (en) * | 2000-04-20 | 2003-04-22 | Bristol-Myers Squibb Company | Taste masking coating composition |
US6316029B1 (en) * | 2000-05-18 | 2001-11-13 | Flak Pharma International, Ltd. | Rapidly disintegrating solid oral dosage form |
US6620351B2 (en) * | 2000-05-24 | 2003-09-16 | Auburn University | Method of forming nanoparticles and microparticles of controllable size using supercritical fluids with enhanced mass transfer |
US6656492B2 (en) | 2000-06-30 | 2003-12-02 | Yamanouchi Pharmaceutical Co., Ltd. | Quick disintegrating tablet in buccal cavity and manufacturing method thereof |
AU2001277230A1 (en) * | 2000-08-01 | 2002-02-13 | Inhale Therapeutic Systems, Inc. | Apparatus and process to produce particles having a narrow size distribution andparticles made thereby |
FR2815540B1 (en) | 2000-10-19 | 2005-06-10 | Separex Sa | PROCESS FOR MANUFACTURING VERY FINE PARTICLES COMPRISING A PRINCIPLE INSERTED IN A HOST MOLECULE |
GB0027357D0 (en) * | 2000-11-09 | 2000-12-27 | Bradford Particle Design Plc | Particle formation methods and their products |
GB0102075D0 (en) | 2001-01-26 | 2001-03-14 | Astrazeneca Ab | Process |
GB0117696D0 (en) * | 2001-07-20 | 2001-09-12 | Bradford Particle Design Plc | Particle information |
TW586963B (en) | 2001-07-20 | 2004-05-11 | Nektar Therapeutics Uk Ltd | Method and apparatus for preparing target substance in particulate form and fluid inlet assembly for said apparatus |
EP1446104B2 (en) * | 2001-11-01 | 2011-08-03 | Novartis AG | Spray drying methods |
WO2003075829A2 (en) * | 2002-03-08 | 2003-09-18 | M/S. Ind-Swift Limited | Tasteless directly compressible fast-dissolving complexes and pharmaceutical formulations thereof |
US7354601B2 (en) * | 2003-05-08 | 2008-04-08 | Walker Stephen E | Particulate materials |
JP4187739B2 (en) | 2005-10-17 | 2008-11-26 | 電気化学工業株式会社 | Aluminum alloy-silicon carbide silicon nitride composite |
JP5057166B2 (en) | 2008-10-30 | 2012-10-24 | アイシン・エィ・ダブリュ株式会社 | Safe driving evaluation system and safe driving evaluation program |
-
2000
- 2000-11-09 GB GB0027357A patent/GB0027357D0/en not_active Ceased
-
2001
- 2001-11-01 GB GB0217667A patent/GB2380147A/en not_active Withdrawn
- 2001-11-01 CA CA2426247A patent/CA2426247C/en not_active Expired - Lifetime
- 2001-11-01 JP JP2002540717A patent/JP4880863B2/en not_active Expired - Lifetime
- 2001-11-01 KR KR1020037006171A patent/KR100822098B1/en active IP Right Grant
- 2001-11-01 GB GB0126193A patent/GB2371501B/en not_active Expired - Fee Related
- 2001-11-01 AU AU1076502A patent/AU1076502A/en active Pending
- 2001-11-01 ES ES01978670T patent/ES2299519T3/en not_active Expired - Lifetime
- 2001-11-01 AT AT01978670T patent/ATE382336T1/en not_active IP Right Cessation
- 2001-11-01 US US10/004,522 patent/US7115280B2/en not_active Expired - Lifetime
- 2001-11-01 EP EP01978670A patent/EP1331928B1/en not_active Revoked
- 2001-11-01 DE DE60132230T patent/DE60132230T2/en not_active Revoked
- 2001-11-01 MX MXPA03003846A patent/MXPA03003846A/en active IP Right Grant
- 2001-11-01 AU AU2002210765A patent/AU2002210765B9/en not_active Expired
- 2001-11-01 WO PCT/GB2001/004873 patent/WO2002038127A2/en active IP Right Grant
- 2001-11-05 TW TW90127442A patent/TWI241198B/en not_active IP Right Cessation
-
2006
- 2006-07-17 US US11/458,008 patent/US9120031B2/en active Active
-
2015
- 2015-08-31 US US14/841,325 patent/US20150366241A1/en not_active Abandoned
-
2017
- 2017-07-18 US US15/653,059 patent/US10798955B2/en not_active Expired - Lifetime
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5424076A (en) * | 1990-12-22 | 1995-06-13 | Schwarz Pharma Ag | Method of producing microscopic particles made of hydrolytically decomposable polymers and containing active substances |
US5795594A (en) * | 1993-07-01 | 1998-08-18 | Glaxo Group Limited | Salmeterol xinafoate with controlled particle size |
WO1998013136A1 (en) * | 1996-09-25 | 1998-04-02 | Mainelab | Method for preparing microcapsules of active substances coated with a polymer and novel microcapsules in particular resulting from the method |
WO1999059710A1 (en) * | 1998-05-15 | 1999-11-25 | Bradford Particle Design Plc. | Methods and apparatus for particle formation |
WO2001003821A1 (en) * | 1999-07-07 | 2001-01-18 | Bradford Particle Design Limited | Method of particle formation |
WO2001045731A1 (en) * | 1999-12-21 | 2001-06-28 | Rxkinetix, Inc. | Particulate drug-containing products and method of manufacture |
Non-Patent Citations (6)
Title |
---|
GHADERI RAOUF ET AL: "A new method for preparing biodegradable microparticles and entrapment of hydrocortisone in DL-PLG microparticles using supercritical fluids.", EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, vol. 10, no. 1, March 2000 (2000-03-01), pages 1 - 9, XP001009836, ISSN: 0928-0987 * |
HE PING ET AL: "Chitosan microspheres prepared by spray drying.", INTERNATIONAL JOURNAL OF PHARMACEUTICS (AMSTERDAM), vol. 187, no. 1, pages 53 - 65, XP001009857, ISSN: 0378-5173 * |
MEYER J D ET AL: "PREPARATION AND IN VITRO CHARACTERIZATION OF GENTAMYCIN-IMPREGNATEDBIODEGRADABLE BEADS SUITABLE FOR TREATMENT OF OSTEOMYELITIS", JOURNAL OF PHARMACEUTICAL SCIENCES,AMERICAN PHARMACEUTICAL ASSOCIATION. WASHINGTON,US, vol. 87, no. 9, 1 September 1998 (1998-09-01), pages 1149 - 1154, XP000773117, ISSN: 0022-3549 * |
MONEGHINI M ET AL: "Processing of carbamazepine-PEG 4000 solid dispersions with supercritical carbon dioxide: preparation, characterisation, and in vitro dissolution.", INTERNATIONAL JOURNAL OF PHARMACEUTICS. NETHERLANDS 3 JUL 2001, vol. 222, no. 1, 3 July 2001 (2001-07-03), pages 129 - 138, XP002208722, ISSN: 0378-5173 * |
VUDATHALA G K ET AL: "MICROENCAPSULATION OF SOLID DISPERSIONS: RELEASE OF GRISEOFULVIN FROM GRISEOFULVIN: PHOSPHOLIPID COPRECIPITATES IN MICROSPHERES", PHARMACEUTICAL RESEARCH,US,NEW YORK, NY, vol. 9, no. 6, 1 June 1992 (1992-06-01), pages 759 - 763, XP000560913, ISSN: 0724-8741 * |
WILKINS S A ET AL: "THE FORMATION OF INDOMETHACIN: POLYMER CO-PRECIPITATES BY THE SOLUTION ENHANCED DISPERSION BY SUPERCRITICAL FLUIDS (SEDS) PROCESS", JOURNAL OF PHARMACY AND PHARMACOLOGY,GB,LONDON, vol. 51, no. SUPPL, 1999, pages 291, XP000905174, ISSN: 0022-3573 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9120031B2 (en) | 2000-11-09 | 2015-09-01 | Nektar Therapeutics | Compositions of particulate coformulation |
Also Published As
Publication number | Publication date |
---|---|
AU1076502A (en) | 2002-05-21 |
US7115280B2 (en) | 2006-10-03 |
GB0027357D0 (en) | 2000-12-27 |
KR100822098B1 (en) | 2008-04-15 |
US20020114844A1 (en) | 2002-08-22 |
US20100222220A1 (en) | 2010-09-02 |
ATE382336T1 (en) | 2008-01-15 |
CA2426247C (en) | 2011-03-08 |
GB2371501B (en) | 2003-05-14 |
US20170318839A1 (en) | 2017-11-09 |
GB2380147A (en) | 2003-04-02 |
TWI241198B (en) | 2005-10-11 |
JP2004512942A (en) | 2004-04-30 |
US9120031B2 (en) | 2015-09-01 |
JP4880863B2 (en) | 2012-02-22 |
GB2371501A (en) | 2002-07-31 |
EP1331928A2 (en) | 2003-08-06 |
AU2002210765B2 (en) | 2006-05-11 |
DE60132230T2 (en) | 2009-01-02 |
GB0217667D0 (en) | 2002-09-11 |
US10798955B2 (en) | 2020-10-13 |
WO2002038127A2 (en) | 2002-05-16 |
GB0126193D0 (en) | 2002-01-02 |
EP1331928B1 (en) | 2008-01-02 |
KR20030051781A (en) | 2003-06-25 |
MXPA03003846A (en) | 2004-10-28 |
ES2299519T3 (en) | 2008-06-01 |
AU2002210765B9 (en) | 2006-06-15 |
DE60132230D1 (en) | 2008-02-14 |
US20150366241A1 (en) | 2015-12-24 |
CA2426247A1 (en) | 2002-05-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002038127A3 (en) | Particle formation methods and their products | |
WO2004098561A3 (en) | Particulate materials | |
WO2007051520A3 (en) | Method and device for producing very fine particles and coating such particles | |
WO2008093347A3 (en) | Method for preparing particles comprising metal oxide coating and particles with metal oxide coating | |
ATE340657T1 (en) | SELF-CLEANING SURFACES THROUGH HYDROPHOBIC STRUCTURES AND METHOD FOR THEIR PRODUCTION | |
AU1973499A (en) | Improved magnetic particles, method for obtaining same and uses for separating molecules | |
ATE257698T1 (en) | HYDROPHILIC MICROPARTICLES AND METHOD FOR THE PRODUCTION THEREOF | |
WO2005102269A3 (en) | An amine drug-containing slow-release granule preparation based on particles with a coating layer and the corresponding method of production | |
ATE406957T1 (en) | MODIFIED PHOTOCATALYST COMPOSITION | |
ATE494886T1 (en) | METHOD FOR PRODUCING MICRO CAPSULES | |
WO2009124015A3 (en) | Methods, systems, and devices for separating materials using magnetic and frictional properties | |
WO2003024595A8 (en) | A process for making rare earth metal oxide-coated microporous materials | |
DE60003933D1 (en) | METHOD FOR PRODUCING MICROPARTICLES | |
SE9801287D0 (en) | Incorporation of active substances into carrier matrixes | |
DE60203975D1 (en) | Process for the preparation of magnetic particles, magnetic particles and magnetic material | |
ATE444731T1 (en) | FLAVOR-MASKED COATED PARTICLES, METHOD OF PRODUCTION AND ORAL-DISPPERSIBLE TABLETS CONTAINING THE COATED PARTICLES | |
CN107913651A (en) | A kind of cinnamyl aldehyde microcapsule preparation method | |
MY158434A (en) | Water-in-oil emulsion and method of producing the same | |
ATE392203T1 (en) | METHOD FOR ENCAPSULATING AN ACTIVE SUBSTANCE | |
AU2001275324A1 (en) | Method of forming catalyst structure with catalyst particles forged into substrate surface | |
JPS5719032A (en) | Method of and apparatus for production of multiphase droplet | |
WO1998020856A3 (en) | Microparticles containing active substances, agents containing the same, their use in ultrasound-controlled releasing of active substances as well as the method for their production | |
WO2002044091A3 (en) | A method for the purification of water by means of filtration using a micro or ultra filtration membrane | |
ATE261338T1 (en) | METHOD FOR ENCAPSULATING ACTIVE MATERIALS BY COAZERVATION OF POLYMERS IN NON-CHLORINATED ORGANIC SOLVENT | |
EP0933390A4 (en) | Method for washing prefoamed particles |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 406/KOLNP/2003 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001978670 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002210765 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2426247 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2003/003846 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020037006171 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002540717 Country of ref document: JP |
|
WWP | Wipo information: published in national office |
Ref document number: 1020037006171 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 2001978670 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWG | Wipo information: grant in national office |
Ref document number: 2001978670 Country of ref document: EP |